{ "ok": true, "cik": "1040130", "ticker": "PETS", "name": "PETMED EXPRESS, INC.", "filings": [ { "form": "8-K", "filed": "2026-09-17", "items": [ "5.02 Departure or Election of Directors; Appointment of Officers", "7.01 Regulation FD Disclosure", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/1040130/000104013026000045/0001040130-26-000045-index.htm" }, { "form": "10-Q", "filed": "2026-08-13", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/1040130/000104013026000041/0001040130-26-000041-index.htm" }, { "form": "8-K", "filed": "2026-08-13", "items": [ "2.02 Results of Operations and Financial Condition", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/1040130/000104013026000040/0001040130-26-000040-index.htm" }, { "form": "8-K", "filed": "2026-08-12", "items": [ "5.02 Departure or Election of Directors; Appointment of Officers", "5.07 Submission of Matters to a Vote of Security Holders", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/1040130/000104013026000036/0001040130-26-000036-index.htm" }, { "form": "8-K", "filed": "2026-07-23", "items": [ "1.01 Entry into a Material Definitive Agreement", "7.01 Regulation FD Disclosure", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/1040130/000104013026000029/0001040130-26-000029-index.htm" }, { "form": "8-K", "filed": "2026-06-26", "items": [ "5.02 Departure or Election of Directors; Appointment of Officers", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/1040130/000104013026000027/0001040130-26-000027-index.htm" } ], "events12m": 14, "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001040130.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1040130" }, "license": "Figures as filed with the SEC. Card text CC BY 4.0, POPS4.", "notAdvice": "Reporting, not investment advice. No price targets, no buy or sell views.", "edgar": "🫧 Edgar looked up PETMED EXPRESS, INC. ($PETS). Last filing: 8-K (5.02 Departure or Election of Directors; Appointment of Officers), 2026-09-17. 14 event filings (8-K) in the past twelve months. Auditor change (8-K Item 4.01) filed 2025-12-29. Non-reliance (8-K Item 4.02) filed 2025-10-07.", "auditor": { "changes": [ { "filed": "2025-12-29", "url": "https://www.sec.gov/Archives/edgar/data/1040130/000104013025000112/0001040130-25-000112-index.htm" }, { "filed": "2025-12-09", "url": "https://www.sec.gov/Archives/edgar/data/1040130/000104013025000097/0001040130-25-000097-index.htm" } ], "nonReliance": [ { "filed": "2025-10-07", "url": "https://www.sec.gov/Archives/edgar/data/1040130/000104013025000064/0001040130-25-000064-index.htm" } ], "restatedSince": true }, "metrics": { "fiscalYearEnd": "2026-03-31", "revenue": 179021000, "revenueGrowth1y": -0.21126394445129792, "revenueGrowthPerYear": -0.0995258257609205, "yearsOfData": 5, "operatingMargin": -0.3277436725300384, "operatingMarginPrior": -0.0067409195847946005, "netMargin": -0.3199959781254713, "operatingCashFlow": -28394000, "capitalSpending": 4615000, "freeCashFlow": -33009000, "researchAndDevelopment": null, "researchShareOfRevenue": null, "cash": 21412000, "longTermDebt": null, "longTermDebtChange": null, "revenueHistory": [ { "fiscalYearEnd": "2022-03-31", "revenue": 272282000 }, { "fiscalYearEnd": "2023-03-31", "revenue": 256579000 }, { "fiscalYearEnd": "2024-03-31", "revenue": 281064000 }, { "fiscalYearEnd": "2025-03-31", "revenue": 226972000 }, { "fiscalYearEnd": "2026-03-31", "revenue": 179021000 } ], "totalEquity": 28940000, "totalAssets": 81191000, "equityRatio": 0.35644344816543705, "returnOnEquity": -1.9794747753973738, "dividendsPaid": 21000, "payoutRatio": null, "dividendPerShare": 0, "dividendYearsRising": 0, "dividendCut": false, "priceBased": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown.", "range80": { "low": 118312593.5347002, "high": 190158095.94737947, "baseline": 149990610.46488363, "n": 4309, "band": "b01" }, "ifPaceHeld": { "low": 118312593.5347002, "high": 190158095.94737947 } }, "edgarette": "🔖 Exposure: revenue $179.0M (FY2026). Experience: revenue down 21.1% on the year, down 10.0% a year over 4 years; operating margin -32.8%, down from -0.7%. Soundness: equity 35.6% of assets, return on equity -197.9%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $118.3M and $190.2M next year (method v3, set from 4,309 SEC company-years; on a year the method never saw, 83% landed inside). A range, not a forecast. Against peers (57 filers, $50M+ revenue, its industry group): operating margin -32.8% against a 0.6% median; growth -21.1% against 4.1%.", "peers": { "sic": 5912, "sicDescription": "Retail-Drug Stores and Proprietary Stores", "calendarYear": 2025, "minRevenue": 50000000, "depth": 2, "group": "59", "growth": [ 0.0413, 57 ], "opMargin": [ 0.0057, 57 ], "equityRatio": [ 0.2951, 52 ], "returnOnEquity": [ 0.0257, 40 ], "payoutRatio": [ 0.2479, 13 ] }, "summary": "Petmed Express (PETS) saw revenue fall 21.1% in FY2026 to $179 million, operating margin -32.8% against a 0.6% median for retail-drug stores and proprietary stores, equity 35.6% of assets. Every figure is from the company’s own annual report filed with the SEC.", "chart": "
PETMED EXPRESS, INC. against its own record and its peers
Operating marginPeer median 0.6%-32.8%Revenue, on the yearPeer median 4.1%-21.1%Equity of assetsPeer median 29.5%35.6%Return on equityPeer median 2.6%-197.9%Gold tick: the median of 40–52 peers with $50M+ revenue in retail-drug stores and proprietary stores
", "chartHorizon": "
Handed back now, or kept to compound
Of each dollar of profitHanded back per share$0Revenue growth it managed-21.1%last year, for comparison

Gold is paid out to shareholders; navy is kept in the business. Retained profit times return on equity is the pace a company can fund from itself. Facts from the filings, not a recommendation.

", "backtest": { "tests": 7, "hits": 6, "rate": 0.8571428571428571, "method": "v3", "note": "hindsight: past years, same calibrated range. The range was calibrated on 2022-2024 SEC data, so years in that window are partly in-sample." }, "registry": { "logged": "2026-09-20T13:14:23.955Z", "hash": "2cf611d40d3111a7", "status": "open" }, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "schema": "pops4.edgarette.card/1", "card": { "summary": "Petmed Express (PETS) saw revenue fall 21.1% in FY2026 to $179 million, operating margin -32.8% against a 0.6% median for retail-drug stores and proprietary stores, equity 35.6% of assets. Every figure is from the company’s own annual report filed with the SEC.", "exposure": { "fiscalYearEnd": "2026-03-31", "revenue": 179021000, "totalDebt": null, "cash": 21412000 }, "experience": { "revenueGrowth1y": -0.21126394445129792, "revenueGrowthPerYear": -0.0995258257609205, "operatingMargin": -0.3277436725300384, "operatingMarginPrior": -0.0067409195847946005, "netMargin": -0.3199959781254713, "freeCashFlow": -33009000 }, "soundness": { "equityRatio": 0.35644344816543705, "returnOnEquity": -1.9794747753973738, "payoutRatio": null, "dividendPerShare": 0, "dividendYearsRising": 0, "dividendCut": false, "note": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown." }, "peers": { "sic": 5912, "sicDescription": "Retail-Drug Stores and Proprietary Stores", "calendarYear": 2025, "minRevenue": 50000000, "depth": 2, "group": "59", "growth": [ 0.0413, 57 ], "opMargin": [ 0.0057, 57 ], "equityRatio": [ 0.2951, 52 ], "returnOnEquity": [ 0.0257, 40 ], "payoutRatio": [ 0.2479, 13 ] }, "credibility": { "auditedYears": 5, "weight": "reasonable", "standard": "ASOP No. 25", "nonReliance": { "filed": "2025-10-07", "url": "https://www.sec.gov/Archives/edgar/data/1040130/000104013025000064/0001040130-25-000064-index.htm", "restatedSince": true, "markedDown": false }, "auditorChange": { "filed": "2025-12-29", "url": "https://www.sec.gov/Archives/edgar/data/1040130/000104013025000112/0001040130-25-000112-index.htm" } }, "range": { "low": 118312593.5347002, "high": 190158095.94737947, "baseline": 149990610.46488363, "coverage": 0.8, "method": "v3", "basis": "next fiscal year revenue: baseline = revenue x (1 + mean of one-year and three-year pace); range = 10th to 90th percentile of how SEC company-years of the same size band actually turned out", "calibratedOn": { "companyYears": 4309, "sizeBand": "b01" }, "kind": "a calibrated range, not a forecast; no view on the share price", "track": { "backtest": { "tests": 7, "hits": 6, "rate": 0.8571428571428571, "method": "v3", "note": "hindsight: past years, same calibrated range. The range was calibrated on 2022-2024 SEC data, so years in that window are partly in-sample." }, "registry": { "logged": "2026-09-20T13:14:23.955Z", "hash": "2cf611d40d3111a7", "status": "open" }, "scorecard": "https://www.pops4.com/boards/scorecard" } }, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001040130.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1040130" } }, "definitions": { "operatingMargin": "Operating income divided by revenue.", "netMargin": "Net income divided by revenue.", "freeCashFlow": "Cash from operations minus spending on property and equipment.", "researchShareOfRevenue": "Research and development expense for the year as a share of revenue, both as filed.", "equityRatio": "Shareholders equity as a share of total assets, both as filed. Higher means less of the company is owed to someone else.", "returnOnEquity": "Net income for the year against shareholders equity at year end.", "payoutRatio": "Dividends paid as a share of net income, in the year the cash went out.", "dividendYearsRising": "Consecutive years, counted back from the last on record, in which dividend per share rose. A fall ends the run and is reported as dividendCut.", "revenueGrowthPerYear": "Compound annual growth between the first and latest fiscal years shown.", "credibility": "How much weight a record deserves, in the actuarial sense (ASOP No. 25): more audited years, more weight.", "peers": "Medians of SEC filers with $50M+ revenue in the same industry code (SIC), narrowest group with at least 8 filers, calendar-year figures from SEC XBRL frames.", "backtest": "The same if-the-pace-held arithmetic applied to the company's own past years, scored against what it actually reported next. Hindsight, and labelled so." } }